tiprankstipranks
BioXcel Therapeutics advances Phase 3 trials of BXCL501
PremiumThe FlyBioXcel Therapeutics advances Phase 3 trials of BXCL501
1M ago
BTAI Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
BTAI Earnings Report this Week: Is It a Buy, Ahead of Earnings?
1M ago
BioXcel Therapeutics price target lowered to $5 from $7 at H.C. Wainwright
Premium
The Fly
BioXcel Therapeutics price target lowered to $5 from $7 at H.C. Wainwright
2M ago
BioXcel Therapeutics announces initiation of SERENITY Phase 3 trial
PremiumThe FlyBioXcel Therapeutics announces initiation of SERENITY Phase 3 trial
4M ago
BioXcel Therapeutics price target lowered to $7 from $10 at H.C. Wainwright
Premium
The Fly
BioXcel Therapeutics price target lowered to $7 from $10 at H.C. Wainwright
5M ago
BioXcel Therapeutics reports Q2 EPS (21c), consensus (71c)
Premium
The Fly
BioXcel Therapeutics reports Q2 EPS (21c), consensus (71c)
5M ago
BioXcel Therapeutics reports Q1 EPS (87c), consensus (70c)
PremiumThe FlyBioXcel Therapeutics reports Q1 EPS (87c), consensus (70c)
8M ago
Bioxcel Therapeutics Advances SERENITY Trial and Strategy
Premium
Company Announcements
Bioxcel Therapeutics Advances SERENITY Trial and Strategy
8M ago
BioXcel announces plan for evaluating BXCL501 in at-home setting
Premium
The Fly
BioXcel announces plan for evaluating BXCL501 in at-home setting
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100